The Role of the BMI ≥ 40 kg/m2 Criterium in ASA-PS Classification for Metabolic Surgery - Scorecard - MDSpire

The Role of the BMI ≥ 40 kg/m2 Criterium in ASA-PS Classification for Metabolic Surgery

  • By

  • Elisabeth S. van Ede

  • Simon W. Nienhuijs

  • Marc P. Buise

  • R. Arthur Bouwman

  • July 29, 2025

  • 0 min

Share

Clinical Scorecard: The Impact of a BMI of 40 kg/m2 or Higher on ASA-PS Classification in Metabolic Surgery

At a Glance

CategoryDetail
ConditionObesity and its impact on peri-operative risk classification
Key MechanismsBMI ≥ 40 kg/m2 as a criterion for ASA-PS classification; metabolic health status influencing peri-operative risk
Target PopulationPatients undergoing metabolic surgery with BMI ≥ 30 kg/m2, focusing on those with BMI ≥ 40 kg/m2
Care SettingMetabolic surgery centers following standardized surgical and anesthesia practices aligned with ERAS guidelines

Key Highlights

  • ASA-PS classification includes BMI ≥ 40 kg/m2 as a criterion since 2014, but its evidence basis is unclear.
  • Metabolically healthy obesity differs from metabolically unhealthy obesity, affecting peri-operative risk.
  • Increased BMI alone does not reliably predict peri-operative complications or morbidity after metabolic surgery.

Guideline-Based Recommendations

Diagnosis

  • Use BMI along with assessment of obesity-related comorbidities to evaluate peri-operative risk.
  • Differentiate patients by metabolic health status rather than BMI alone for ASA-PS classification.

Management

  • Apply standardized metabolic surgery and anesthesia protocols consistent with ERAS guidelines.
  • Consider metabolic and cardiovascular comorbidities in peri-operative risk stratification beyond BMI.

Monitoring & Follow-up

  • Monitor peri-operative morbidity and mortality with attention to comorbidity profiles.
  • Use validated indices such as the Charlson Comorbidity Index for comprehensive risk assessment.

Risks

  • Recognize that BMI ≥ 40 kg/m2 alone may not increase peri-operative risk without severe systemic disease.
  • Obesity-related complications, not adipose tissue volume alone, contribute to anesthesia and surgical risks.

Patient & Prescribing Data

Patients undergoing primary or first-stage metabolic surgery with BMI ≥ 30 kg/m2

Patients with BMI ≥ 40 kg/m2 but no severe systemic disease may have lower complication rates than those with severe comorbidities despite similar ASA-PS III classification.

Clinical Best Practices

  • Assess both BMI and presence/severity of obesity-related comorbidities for accurate ASA-PS classification.
  • Avoid assigning higher ASA-PS scores solely based on BMI ≥ 40 kg/m2 without considering metabolic health.
  • Utilize comprehensive data registries like DATO for quality assurance and outcome monitoring in metabolic surgery.
  • Incorporate ERAS protocols to optimize peri-operative care in patients with obesity.

References

Original Source(s)

Related Content